Glaucoma optic neuropathy
Conditions
Interventions
Control Group:Mecobalamin for Oral Administration
intervention group:Qingmang Yihao Granules for oral administration
Sponsors
Dongfang Hospital of Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1) Confirmed presence of optic nerve damage through visual field testing OCT and other relevant examinations; 2) Intraocular pressure (IOP) 3 months; 4) Age between 18 and 80 years; 5) Meeting diagnostic criteria for Liver Depression and Spleen Deficiency Syndrome according to Traditional Chinese Medicine (TCM) classification; 6) Voluntary enrollment with written informed consent obtained
Exclusion criteria
Exclusion criteria: 1)Hypersensitivity to the investigational drug(s) in this study; 2)Comorbid psychiatric disorders or severe systemic organic diseases (e.g. uncompensated cardiac/respiratory failure advanced malignancies); 3)Participation in other ophthalmic clinical trials within the past 30 days or concomitant use of medications with documented efficacy against glaucomatous optic neuropathy (GON) within the past month; 4)Concurrent organic ocular pathologies (e.g. uveitis ocular trauma retinal vascular occlusions); 5)Pregnancy lactation or plans for conception during the study period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Field;BCVA; | — |
Secondary
| Measure | Time frame |
|---|---|
| RNFL;TCM Syndrome Assessment Score;IOP; | — |
Countries
China
Contacts
Public ContactLiaoliang
Dongfang Hospital of Beijing University of Chinese Medicine
Outcome results
None listed